V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215276 | 20130322 | 1.57 | null | Curative (C) | 2017-01-09 | 2017-02-27 | EOX | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101214701 |
| 20215278 | 20130323 | 1.6 | 57.1 | null | 2021-11-12 | 2021-12-14 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100168435 |
| 20215280 | 20130324 | null | 61 | Curative (C) | 2018-09-01 | 2019-07-07 | Trial Unspecified | 2 | N | TRIAL | 100568913 |
| 20215281 | 20130325 | 1.63 | 68 | null | 2017-01-26 | 2017-02-10 | EOX | 02 | null | CAPECITABINE + RT | 100433127 |
| 20215282 | 20130326 | 1.75 | 72 | Palliative (P) | 2017-09-13 | 2018-03-05 | EOX | 2 | N | EOX | 101620680 |
| 20215284 | 20130327 | 1.52 | 63.6 | Palliative (P) | 2018-05-13 | 2018-05-30 | Sorafenib | 02 | N | SORAFENIB | 101692849 |
| 20215287 | 20130328 | 1.59 | 84.3 | Palliative (P) | 2021-05-03 | 2021-05-03 | EOX | 02 | Y | EOX | 101558037 |
| 20215289 | 20130329 | 1.71 | 70.8 | Neo-adjuvant (N) | null | 2020-09-01 | Sorafenib | 02 | N | SORAFENIB | 101488446 |
| 20215292 | 20130330 | 1.72 | 86.1 | Neo-adjuvant (N) | 2018-12-04 | 2018-12-27 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100837498 |
| 20215294 | 20130331 | 1.78 | 61 | null | 2020-10-19 | 2020-11-15 | EOX | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101140458 |
| 20215295 | 20130332 | 0 | 42 | 03 | 2017-06-22 | 2017-06-29 | Sorafenib | 02 | Y | SORAFENIB | 101035202 |
| 20215296 | 20130333 | 1.87 | 111.05 | Palliative (P) | 2016-12-28 | 2016-12-28 | CAPECITABINE + RT | 2 | N | CAPECITABINE + RT | 100967309 |
| 20215298 | 20130334 | 1.59 | 101.3 | Curative (C) | 2016-11-25 | 2016-12-11 | EOX | 02 | Y | OXALIPLATIN + RALTITREXED | 100437023 |
| 20215299 | 20130335 | 1.76 | 53.9 | Neo-adjuvant (N) | 2018-01-15 | 2018-01-15 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101097894 |
| 20215301 | 20130336 | 1.6 | 96 | Adjuvant (A) | 2019-02-13 | 2019-02-13 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101231578 |
| 20215304 | 20130337 | 1.55 | 76.7 | Neo-adjuvant (N) | 2016-08-19 | 2016-08-20 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100735680 |
| 20215305 | 20130338 | 1.49 | 77.3 | Palliative (P) | 2018-10-31 | 2018-10-31 | Sorafenib | 02 | N | SORAFENIB | 101694657 |
| 20215306 | 20130339 | null | 77.8 | Palliative (P) | 2018-08-11 | 2019-06-02 | Oxaliplatin + Raltitrexed | null | N | OXALIPLATIN + RALTITREXED | 100856600 |
| 20215307 | 20130340 | 1.65 | 78.3 | Palliative (P) | 2018-06-07 | 2018-06-21 | EOX | 02 | null | CAPECITABINE + RT | 101182137 |
| 20215317 | 20130341 | 1.55 | 83.9 | Curative (C) | 2017-11-10 | 2017-11-21 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 100633123 |
| 20215318 | 20130342 | 1.69 | 46.8 | null | 2017-05-10 | 2017-05-20 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101365667 |
| 20215319 | 20130343 | 1.62 | 92.3 | Curative (C) | 2016-02-11 | 2016-03-07 | EOX | 02 | N | SORAFENIB | 100558155 |
| 20215320 | 20130344 | 1.52 | 65 | Palliative (P) | 2019-02-26 | 2019-03-12 | EOX | 02 | N | EOX | 101471011 |
| 20215321 | 20130345 | 1.75 | 82 | Palliative (P) | 2020-05-14 | 2020-06-13 | Trial Unspecified | Y | N | TRIAL | 101380522 |
| 20215322 | 20130346 | 1.58 | 74.8 | Curative (C) | 2016-10-29 | 2016-10-30 | EOX | N | N | CAPECITABINE + RT | 100848124 |
| 20215323 | 20130347 | null | 59.8 | Curative (C) | 2017-10-18 | 2017-10-23 | Sorafenib | 99 | N | SORAFENIB | 101663320 |
| 20215324 | 20130348 | 1.75 | 66.1 | Palliative (P) | 2019-01-15 | 2019-06-25 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100686775 |
| 20215325 | 20130349 | 1.6 | 73.9 | Palliative (P) | 2017-07-23 | 2017-08-01 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101268619 |
| 20215327 | 20130350 | 1.86 | null | Neo-adjuvant (N) | 2019-11-22 | 2019-11-22 | EOX | 02 | Y | TRIAL | 100229588 |
| 20215328 | 20130351 | null | 48.6 | Palliative (P) | 2018-02-04 | 2018-03-03 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100874783 |
| 20215329 | 20130352 | 1.57 | 72.5 | null | 2017-11-04 | 2017-11-18 | EOX | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101630768 |
| 20215330 | 20130353 | 1.6 | 68.9 | null | 2017-07-18 | 2017-07-24 | Oxaliplatin + Raltitrexed | N | null | OXALIPLATIN + RALTITREXED | 101179107 |
| 20215333 | 20130354 | 1.53 | 85 | Palliative (P) | 2019-05-31 | 2019-06-14 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101635695 |
| 20215334 | 20130355 | 1.69 | 63.35 | 03 | 2021-05-27 | 2021-06-10 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100547247 |
| 20215335 | 20130356 | null | 102 | Palliative (P) | 2019-04-19 | 2019-05-04 | Trial Unspecified | 99 | Y | EOX | 101038282 |
| 20215337 | 20130357 | 1.46 | 44.3 | Palliative (P) | 2020-04-01 | 2020-04-15 | Sorafenib | 02 | N | SORAFENIB | 100853397 |
| 20215338 | 20130358 | 1.72 | 119.8 | null | 2016-05-11 | 2016-05-16 | Sorafenib | 2 | null | SORAFENIB | 100170146 |
| 20215340 | 20130359 | 1.9 | 95 | Palliative (P) | 2019-09-24 | 2019-10-27 | Sorafenib | 02 | null | SORAFENIB | 101486981 |
| 20215343 | 20130360 | 1.67 | 69.6 | Neo-adjuvant (N) | 2017-03-25 | 2017-03-25 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 101695982 |
| 20215344 | 20130361 | 1.6 | 68.5 | Not known (9) | 2019-07-23 | 2019-08-08 | Oxaliplatin + Raltitrexed | 02 | Y | OXALIPLATIN + RALTITREXED | 101742935 |
| 20215346 | 20130362 | 1.5 | 67.5 | Neo-adjuvant (N) | 2022-03-07 | 2022-03-22 | IRINOTECAN + MDG + PANITUMUMAB | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101019227 |
| 20215347 | 20130363 | 1.74 | 63 | Palliative (P) | 2021-05-14 | 2021-05-30 | Oxaliplatin + Raltitrexed | 01 | N | OXALIPLATIN + RALTITREXED | 101831025 |
| 20215348 | 20130364 | 1.69 | 75.4 | null | 2019-10-31 | 2020-03-10 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101836126 |
| 20215349 | 20130365 | 1.72 | 86 | Adjuvant (A) | 2015-05-07 | 2019-01-30 | Sorafenib | 02 | N | SORAFENIB | 101565501 |
| 20215351 | 20130366 | 1.7 | 86 | Palliative (P) | 2017-10-14 | 2018-07-05 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101417693 |
| 20215354 | 20130367 | 1.72 | 68.1 | Palliative (P) | 2019-03-21 | 2019-04-11 | Trial Unspecified | 02 | N | TRIAL | 100556544 |
| 20215358 | 20130368 | 1.79 | 46.8 | null | 2019-07-22 | 2019-07-23 | EOX | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101339318 |
| 20215359 | 20130369 | 1.63 | 100.7 | null | 2018-12-25 | 2019-01-22 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100609920 |
| 20215361 | 20130370 | 1.76 | 85 | null | 2019-08-12 | 2019-08-26 | CAPECITABINE + RT | N | Y | CAPECITABINE + RT | 100729202 |
| 20215363 | 20130371 | 1.63 | 90.1 | Palliative (P) | 2019-12-29 | 2020-02-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | SORAFENIB | 100193452 |